Table Of Contents:
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. Thrombectomy Devices Market: By Product Type
- Mechanical Thrombectomy Devices Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Mechanical Thrombectomy Devices Definitions, Technology Landscape
- Mechanical Thrombectomy Devices Market Drivers
- Product Launches
- Technology Launches
- Mechanical Thrombectomy Devices Market Restraints
- Chapter 4. Thrombectomy Devices Market: By End-User
- Hospitals Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Hospitals Definitions, Technology Landscape
- Hospitals Market Drivers
- Product Launches
- Technology Launches
- Hospitals Market Restraints
- Chapter 5. Thrombectomy Devices Market: By Application
- Acute Ischemic Stroke Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Acute Ischemic Stroke Definitions, Technology Landscape
- Acute Ischemic Stroke Market Drivers
- Product Launches
- Technology Launches
- Acute Ischemic Stroke Market Restraints
- Chapter 6. Thrombectomy Devices Market: By Technology
- Mechanical Thrombectomy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Mechanical Thrombectomy Definitions, Technology Landscape
- Mechanical Thrombectomy Market Drivers
- Product Launches
- Technology Launches
- Mechanical Thrombectomy Market Restraints
- Chapter 7. Thrombectomy Devices Market: Regional Market Trends, Size, and Future Outlook
- North America Thrombectomy Devices Market Size (US$), CAGR (%), and Forecast (2021-2031)
- North America Definitions, Technology Landscape
- North America Market Drivers
- Product Launches
- Technology Launches
- North America Market Restraints
- Competitive Outlook
- Europe
- Asia Pacific
- Latin America
- Middle East, and Africa
- Chapter 8. Thrombectomy Devices Market: Competitive Landscape
- Medtronic plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Stryker Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Penumbra, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Boston Scientific Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Terumo Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Acandis GmbH
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Argon Medical Devices, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- AngioDynamics, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Phenox GmbH
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Neuravi Limited (acquired by Johnson & Johnson)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Scitech Medical, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Balt
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Wallaby Medical
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Imperative Care, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Medtronic plc
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Thrombectomy Devices industry is estimated at US$ 1,527.9 million in 2023.
The key factors contributing significantly to the growth of the Thrombectomy Devices market include the increasing incidence of stroke and other vascular disorders, advancements in thrombectomy device technology, growing awareness about the benefits of minimally invasive procedures, and rising demand for effective and time-sensitive clot removal treatments.
The key factors hampering the growth of the Thrombectomy Devices Market include the high cost of thrombectomy devices and procedures, lack of skilled and trained healthcare professionals, reimbursement challenges in certain regions, and complications associated with thrombectomy procedures.
The leading component segment in the Thrombectomy Devices Market is the Mechanical Thrombectomy Devices, which offer improved precision and efficiency in clot removal compared to traditional treatments.
The major players operating in the Thrombectomy Devices Market include Medtronic plc, Stryker Corporation, Johnson & Johnson, Penumbra, Inc., Boston Scientific Corporation, Terumo Corporation, and others.
The Thrombectomy Devices Market is expected to grow at a CAGR of 7.4% from 2024 to 2031, reaching a market size of US$ 2,704.8 million by 2031.
The key drivers of the Thrombectomy Devices Market include the increasing incidence of stroke and other vascular disorders, advancements in thrombectomy device technology, growing awareness about the benefits of minimally invasive procedures, rising demand for effective and time-sensitive clot removal treatments, and the expansion of thrombectomy device applications beyond stroke.